|
|
|
|
adverse reaction to omalizumab in patients with chronic urticaria: flare up or ineffectiveness?
|
|
|
|
|
|
|
|
نویسنده
|
ertaş ragıp ,özyurt kemal ,yıldız sinem ,ulaş yılmaz ,turasan abdullah ,avcı atıl
|
|
منبع
|
iranian journal of allergy, asthma and immunology - 2016 - دوره : 15 - شماره : 1 - صفحه:82 -86
|
|
چکیده
|
Omalizumab is a recombinant humanized anti-ig e monoclonal antibody used as the third line treatment of chronic spontaneous urticaria (csu). we report four patients with severe antihistamine-resistant csu, who developed angioedema, anaphylaxis and/or flare up of urticaria at different times following omalizumab therapy.
|
|
کلیدواژه
|
chronic urticaria ,omalizumab ,adverse reaction
|
|
آدرس
|
kayseri education and research hospital, department of dermatology and venereology, kayseri, turkey, Turkey, kayseri education and research hospital, department of dermatology and venereology, kayseri, turkey, Turkey, kayseri education and research hospital, department of dermatology and venereology, kayseri, turkey, Turkey, kayseri education and research hospital, department of dermatology and venereology, kayseri, turkey, Turkey, kayseri education and research hospital, department of dermatology and venereology, kayseri, turkey, Turkey, kayseri education and research hospital, department of dermatology and venereology, kayseri, turkey, Turkey
|
|
پست الکترونیکی
|
ragipertas@yahoo.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|